Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 343-349

  Park, Hyun Kyung ^a   Kim, Myung Chun ^a   Kim, Sung Min ^a   Jo, Dae Jean ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Angiotensinogen; Haplotype; Intracerebral hemorrhage; Ischemic stroke; Single nucleotide polymorphism

Indexed keywords

ANGIOTENSINOGEN; METHIONINE; THREONINE;

ADULT; AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MODIFIED BARTHEL INDEX; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84869479596     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.790     Document Type: Article

References (43)

1. Grysiewicz RA, Thomas K and Pandey DK: Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 26: 871-895, 567, 2008.
2. van Asch CJ, Luitse MJ, Rinkel GJ, et al: Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9: 167-176, 2010.
3. Wolf PA, Belanger AJ and D'Agostino RB: Management of risk factors. Neurol Clin 10: 177-191, 1992.
4. Lanktree MB, Dichgans M and Hegele RA: Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41: 825-832, 2010.
5. Ikram MA, Seshadri S, Bis JC, et al: Genomewide association studies of stroke. N Engl J Med 360: 1718-1728, 2009.
6. Somarajan BI, Kalita J, Mittal B and Misra UK: Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population. J Neurol Sci 304: 67-70, 2011.
7. Tao HM, Chen GZ, Lu XD, Chen GP and Shao B: TGF-β1 869T/C polymorphism and ischemic stroke: sex difference in Chinese. Can J Neurol Sci 37: 803-807, 2010.
8. Kim NS, Ko MM, Cha MH, Oh SM and Bang OS: Age and sex dependent genetic effects of neuropeptide Y promoter polymorphism on susceptibility to ischemic stroke in Koreans. Clin Chim Acta 411: 1243-1247, 2010.
9. Han IB, Kim OJ, Ahn JY, et al: Association of methylene-tetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population. Yonsei Med J 51: 253-260, 2010.
10. Kim OJ, Hong SP, Ahn JY, et al: Influence of combined methionine synthase (MTR 2756A > G) and methylenetetra-hydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. Yonsei Med J 48: 201-209, 2007.
11. Kim YS, Yoo JH and Lee BC: Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the Fc gamma receptor IIA. Blood Coagul Fibrinolysis 20: 353-357, 2009.
12. Lee BC, Ahn SY, Doo HK, et al: Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett 357: 33-36, 2004.
13. Lee BC, Lee H, Park HK, Yang JS and Chung JH: Susceptibility for ischemic stroke in four constitution medicine is associated with polymorphisms of FCGR2A and IL1RN genes. Neurol Res 32 (Suppl 1): 43-47, 2010.
14. Park SA, Park BL, Park JH, et al: Association of polymorphisms in thromboxane A2 receptor and thromboxane A synthase 1 with cerebral infarction in a Korean population. BMB Rep 42: 200-205, 2009.
15. Kim MK, Kim JT, Choi SM, et al: Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population. J Korean Med Sci 24: 307-310, 2009.
16. Um JY and Kim HM: Polymorphisms of RANTES and IL-4 genes in cerebral infarction. J Mol Neurosci 37: 1-5, 2009.
17. Lee SH, Kim MK, Park MS, et al: beta-Fibrinogen gene -455 G/A polymorphism in Korean ischemic stroke patients. J Clin Neurol 4: 17-22, 2008.
18. Kang SY and Lee WI: Apolipoprotein E polymorphism in ischemic stroke patients with different pathogenetic origins. Korean J Lab Med 26: 210-216, 2006.
19. Shin BS, Oh SY, Kim YS and Kim KW: The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand 117: 237-243, 2008.
20. Lee BC, Doo HK, Ahn SY, et al: Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine. Neurol Res 29 (Suppl 1): S32-S37, 2007.
21. Kim Y, Kim JH, Nam YJ, et al: Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci Lett 407: 189-194, 2006.
22. Seo JC, Han SW, Yin CS, et al: Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients. Exp Mol Med 34: 294-298, 2002.
23. Marciante KD, Bis JC, Rieder MJ, et al: Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol 166: 19-27, 2007.
24. Brenner D, Labreuche J, Poirier O, Cambien F and Amarenco P; GENIC Investigators: Renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann Neurol 58: 131-138, 2005.
25. Hong SH, Park HM, Ahn JY, et al: ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction. Acta Neurol Scand 117: 244-249, 2008.
26. Saidi S, Mallat SG, Almawi WY and Mahjoub T: Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology. Acta Neurol Scand 119: 356-363, 2009.
27. Um JY, Moon KS, Lee KM, et al: Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction. J Mol Neurosci 21: 23-28, 2003.
28. Morimoto S, Cassell MD, Beltz TG, et al: Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fbrillary acidic protein promoter. Circ Res 89: 365-372, 2001.
29. Sherrod M, Davis DR, Zhou X, Cassell MD and Sigmund CD: Glial-specific ablation of angiotensinogen lowers arterial pressure in renin and angiotensinogen transgenic mice. Am J Physiol Regul Integr Comp Physiol 289: R1763-R1769, 2005.
30. Hajjar I, Sorond F, Hsu YH, et al: Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study. Stroke 41: 635-640, 2010.
31. Buroker NE, Ning XH, Zhou ZN, et al: Genetic associations with mountain sickness in Han and Tibetan residents at the Qinghai-Tibetan Plateau. Clin Chim Acta 411: 1466-1473, 2010.
32. Gomez-Gallego F, Santiago C, Gonzalez-Freire M, et al: The C allele of the AGT Met235Thr polymorphism is associated with power sports performance. Appl Physiol Nutr Metab 34: 1108-1111, 2009.
33. Yugar-Toledo JC, Martin J F, Krieger JE, et al: Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol 30: 555-564, 2011.
34. Conen D, Glynn RJ, Buring JE, Ridker PM and Zee RY: Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J Hypertens 26: 1780-1786, 2008.
35. Underwood PC, Sun B, Williams JS, et al: The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach. Metabolism 60: 1150-1157, 2011.
36. Conen D, Glynn RJ, Buring JE, Ridker PM and Zee RY: Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med 263: 376-385, 2008.
37. Ahluwalia TS, Ahuja M, Rai TS, et al: ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 28: 141-150, 2009.
38. Wang QS, Li YG, Chen XD, et al: Angiotensinogen polymorphisms and acquired atrial fbrillation in Chinese. J Electrocardiol 43: 373-377, 2010.
39. Freitas AI, Mendonca I, Brion M, et al: RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. BMC Cardiovasc Disord 8: 15, 2008.
40. Tsai CT, Hwang JJ, Lai L P, et al: Interaction of gender, hypertension, and the angiotensinogen gene haplotypes on the risk of coronary artery disease in a large angiographic cohort. Atherosclerosis 203: 249-256, 2009.
41. Zakrzewski-Jakubiak M, de Denus S, Dube M P, et al: Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Br J Clin Pharmacol 65: 742-751, 2008.
42. Renner W, Nauck M, Winkelmann BR, et al: Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med (Berl) 83: 235-239, 2005.
43. Sethi AA, Tybjaerg-Hansen A, Gronholdt ML, et al: Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 134: 941-954, 2001.